RedPath Integrated Pathology, Inc. — Form D
RedPath Integrated Pathology, Inc. of Pittsburgh, PA, a company, filed a Form D exempt-offering notice with the SEC on 2011-05-16. The offering totals $2.0M, of which $1.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-05-16
- Form: D
- Accession: 0001181431-11-029734
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $1.6M
- Remaining: $400K
- Investors: 12
- Date of first sale: 2011-03-31
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-159850
Issuer
- Name: RedPath Integrated Pathology, Inc.
- CIK: 0001308149
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 2515 Liberty Avenue, Pittsburgh, PA, 15222
- Phone: 412-562-8800
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Jack David | Director | Pittsburgh, PA |
| Mark Myslinski | Director | Pittsburgh, PA |
| Craig S Heryford | Executive Officer | Pittsburgh, PA |
| Dennis Smith | Director | Pittsburgh, PA |
| Dennis Smith | Executive Officer | Pittsburgh, PA |
| Brian Murphy | Director | Red Bank, NJ |
| JACK DAVIS | Director | Pittsburgh, PA |
| Peter Kleinhenz | Director | Pittsburgh, PA |
Other filings by this issuer (2)
More